CuraLeaf Holdings (OTCPK:CURLF -11.5%) is down on double normal volume on the heels of its receipt of a Warning Letter from the FDA over its promotion of unapproved cannabidiol-containing products on its website and social media platforms.
The company has 15 days to submit a written plan to address the violations to the agency. Failure to do so can lead to more serious action, including seizure and injunction.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.